News

3 Penny Stocks That Could Make a Big Comeback by the End of Q2

  • Let's just get something straight off the bat – penny stocks to rebound are risky. They're incredibly treacherous in terms of both short-term downside and longer-term damage to your portfolio.
    04/19/2024

Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward

  • Augmedix is a company developing an AI-driven medical documentation platform for hospitals and physicians. The company's stock performance has been underwhelming since going public, with a current all-time return of -15%. The company's financials show steady growth but continued losses, and there are concerns about profitability and cash flow generation, making risk-reward unattractive for now.
    03/24/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Augmedix, Inc. (AUGX) can hold. Click on Rating Page for detail.

The price of Augmedix, Inc. (AUGX) is 2.85 and it was updated on 2024-04-28 07:00:38.

Currently Augmedix, Inc. (AUGX) is in undervalued.

News
    
News

Augmedix, Inc. (AUGX) Q4 2023 Earnings Call Transcript

  • Augmedix, Inc. (AUGX) Q4 2023 Earnings Call Transcript
    Mon, Mar. 18, 2024

Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

  • SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET.
    Fri, Mar. 08, 2024

Augmedix is an ambient AI healthcare optimization play

  • Augmedix Inc. NASDAQ: AUGX is an artificial intelligence (AI) powered ambient medical documentation solutions provider in the medical sector. It utilizes generative AI for documenting medical records and transcribing medical notes and conversations, which are seamlessly integrated into the electronic health record (EHR) system used by healthcare systems, insurers, offices, and practices.
    Tue, Jan. 09, 2024

Buy Augmedix After $25 Million Equity Funding Round

  • Augmedix dropped in price by 20%+ after announcing a 5.5 million share offering of common stock that was later upsized to 6.25 million shares. Despite concerns of dilution, I rate AUGX a Buy for its revenue growth undergirded by a promising future in the AI marketplace. The Company's product eliminates data entry tasks for doctors, allowing them to focus on delivering care to patients.
    Mon, Nov. 20, 2023

How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%

  • The consensus price target hints at a 36.7% upside potential for Augmedix, Inc. (AUGX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
    Fri, Nov. 10, 2023
SEC Filings
SEC Filings

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 04/18/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/16/2024

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 04/15/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/15/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/11/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/10/2024

Augmedix, Inc. (AUGX) - 4/A

  • SEC Filings
  • 04/09/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/09/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/04/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/03/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/01/2024

Augmedix, Inc. (AUGX) - S-8

  • SEC Filings
  • 03/28/2024

Augmedix, Inc. (AUGX) - 10-K - Current report

  • SEC Filings
  • 03/26/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/19/2024

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/18/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/04/2024

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 02/27/2024

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 02/26/2024

Augmedix, Inc. (AUGX) - SC 13G

  • SEC Filings
  • 02/09/2024

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 01/30/2024

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 01/11/2024

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 01/09/2024

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 01/09/2024

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 01/05/2024

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 12/29/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 12/19/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/29/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/27/2023

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 11/22/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/22/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/21/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/20/2023

Augmedix, Inc. (AUGX) - 424B5

  • SEC Filings
  • 11/17/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/15/2023

Augmedix, Inc. (AUGX) - 424B5

  • SEC Filings
  • 11/15/2023

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 11/13/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/06/2023

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 11/03/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/13/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 09/05/2023

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 08/14/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 08/07/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 07/17/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 07/17/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 07/14/2023

Augmedix, Inc. (AUGX) - DEF 14A

  • SEC Filings
  • 06/26/2023

Augmedix, Inc. (AUGX) - ARS

  • SEC Filings
  • 06/26/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 06/16/2023

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 06/15/2023

Augmedix, Inc. (AUGX) - PRE 14A

  • SEC Filings
  • 06/14/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 06/14/2023

Augmedix, Inc. (AUGX) - S-8

  • SEC Filings
  • 06/12/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 06/09/2023

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 05/30/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 05/25/2023

Augmedix, Inc. (AUGX) - S-3

  • SEC Filings
  • 05/19/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/18/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 05/17/2023

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 05/15/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/12/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/09/2023

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 05/04/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 05/04/2023

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 05/04/2023

Augmedix, Inc. (AUGX) - D

  • SEC Filings
  • 05/03/2023

Augmedix, Inc. (AUGX) - 10-K/A - Current report

  • SEC Filings
  • 05/01/2023

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 04/21/2023

Augmedix, Inc. (AUGX) - 4/A

  • SEC Filings
  • 04/21/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 04/21/2023

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 04/21/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 04/20/2023

Augmedix, Inc. (AUGX) - 10-K - Current report

  • SEC Filings
  • 04/17/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 04/14/2023

Augmedix, Inc. (AUGX) - NT 10-K - Current report

  • SEC Filings
  • 03/31/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/27/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/13/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/06/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/02/2023

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 03/02/2023

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 02/22/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 02/21/2023

Augmedix, Inc. (AUGX) - SC 13G/A

  • SEC Filings
  • 02/14/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 02/06/2023

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 01/26/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 01/12/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 01/10/2023

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 12/28/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 12/21/2022

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 12/16/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 12/15/2022

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 11/18/2022

Augmedix, Inc. (AUGX) - NT 10-Q - Quarterly Report

  • SEC Filings
  • 11/15/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/14/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/02/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 10/06/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 10/04/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 09/30/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 09/28/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 09/27/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 09/22/2022

Augmedix, Inc. (AUGX) - 4/A

  • SEC Filings
  • 09/20/2022

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 09/15/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 09/13/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 09/12/2022

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 09/02/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 09/02/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 08/23/2022

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 08/12/2022

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 08/11/2022

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 08/09/2022

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 08/09/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 08/08/2022

Augmedix, Inc. (AUGX) - RW

  • SEC Filings
  • 07/27/2022

Augmedix, Inc. (AUGX) - POS AM

  • SEC Filings
  • 07/27/2022

Augmedix, Inc. (AUGX) - S-8

  • SEC Filings
  • 07/22/2022

Augmedix, Inc. (AUGX) - S-3

  • SEC Filings
  • 07/22/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 07/13/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 06/22/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 06/21/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 06/10/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 05/27/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/24/2022

Augmedix, Inc. (AUGX) - 424B5

  • SEC Filings
  • 05/24/2022

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 05/13/2022

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 05/12/2022

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 05/09/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/09/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/05/2022

Augmedix, Inc. (AUGX) - CORRESP

  • SEC Filings
  • 05/03/2022

Augmedix, Inc. (AUGX) - DEFA14A

  • SEC Filings
  • 05/02/2022

Augmedix, Inc. (AUGX) - DEF 14A

  • SEC Filings
  • 05/02/2022

Augmedix, Inc. (AUGX) - UPLOAD

  • SEC Filings
  • 04/22/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 04/21/2022

Augmedix, Inc. (AUGX) - S-3

  • SEC Filings
  • 04/15/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/31/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/30/2022

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 03/30/2022

Augmedix, Inc. (AUGX) - 10-K - Current report

  • SEC Filings
  • 03/30/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/21/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/15/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/11/2022

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 03/11/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/08/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/07/2022

Augmedix, Inc. (AUGX) - SC 13G

  • SEC Filings
  • 02/14/2022

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 02/01/2022

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 12/03/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/29/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/24/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/23/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/17/2021

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 11/12/2021

Augmedix, Inc. (AUGX) - 424B3

  • SEC Filings
  • 11/12/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/10/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/09/2021

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 11/09/2021

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 11/01/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 11/01/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/29/2021

Augmedix, Inc. (AUGX) - 424B4

  • SEC Filings
  • 10/28/2021

Augmedix, Inc. (AUGX) - 424B4

  • SEC Filings
  • 10/27/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/26/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/15/2021

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 10/08/2021

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 10/08/2021

Augmedix, Inc. (AUGX) - CERT

  • SEC Filings
  • 10/07/2021

Augmedix, Inc. (AUGX) - 8-A12B

  • SEC Filings
  • 10/07/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/06/2021

Augmedix, Inc. (AUGX) - CORRESP

  • SEC Filings
  • 10/05/2021

Augmedix, Inc. (AUGX) - S-1/A

  • SEC Filings
  • 10/04/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/04/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 09/16/2021

Augmedix, Inc. (AUGX) - UPLOAD

  • SEC Filings
  • 09/09/2021

Augmedix, Inc. (AUGX) - S-1

  • SEC Filings
  • 09/03/2021

Augmedix, Inc. (AUGX) - 424B3

  • SEC Filings
  • 08/17/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 08/16/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 08/10/2021

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 08/10/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 08/06/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 07/22/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 07/08/2021

Augmedix, Inc. (AUGX) - UPLOAD

  • SEC Filings
  • 07/01/2021

Augmedix, Inc. (AUGX) - 10-Q/A - Quarterly Report

  • SEC Filings
  • 06/30/2021

Augmedix, Inc. (AUGX) - 10-K/A - Current report

  • SEC Filings
  • 06/30/2021

Augmedix, Inc. (AUGX) - CORRESP

  • SEC Filings
  • 06/29/2021

Augmedix, Inc. (AUGX) - UPLOAD

  • SEC Filings
  • 06/14/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 06/09/2021

Augmedix, Inc. (AUGX) - DEF 14A

  • SEC Filings
  • 06/08/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 06/03/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 06/01/2021

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 06/01/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 05/27/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 05/21/2021

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 05/17/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 05/13/2021

Augmedix, Inc. (AUGX) - SEC STAFF LETTER

  • SEC Filings
  • 04/14/2021

Augmedix, Inc. (AUGX) - 8-K/A - Current report

  • SEC Filings
  • 04/14/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 04/13/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/31/2021

Augmedix, Inc. (AUGX) - 424B3

  • SEC Filings
  • 03/31/2021

Augmedix, Inc. (AUGX) - 10-K - Current report

  • SEC Filings
  • 03/31/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/30/2021

Augmedix, Inc. (AUGX) - 10-K - Current report

  • SEC Filings
  • 03/30/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/23/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/18/2021

Augmedix, Inc. (AUGX) - SEC STAFF LETTER

  • SEC Filings
  • 03/17/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 03/11/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 03/08/2021

Augmedix, Inc. (AUGX) - SC 13D/A

  • SEC Filings
  • 03/01/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 02/26/2021

Augmedix, Inc. (AUGX) - 424B3

  • SEC Filings
  • 02/08/2021

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 02/05/2021

Augmedix, Inc. (AUGX) - 8-K/A - Current report

  • SEC Filings
  • 02/05/2021

Augmedix, Inc. (AUGX) - EFFECT

  • SEC Filings
  • 02/04/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 02/04/2021

Augmedix, Inc. (AUGX) - CORRESP

  • SEC Filings
  • 02/03/2021

Augmedix, Inc. (AUGX) - S-1/A

  • SEC Filings
  • 02/02/2021

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 01/21/2021

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 12/21/2020

Augmedix, Inc. (AUGX) - UPLOAD

  • SEC Filings
  • 12/16/2020

Augmedix, Inc. (AUGX) - S-8

  • SEC Filings
  • 12/14/2020

Augmedix, Inc. (AUGX) - S-1

  • SEC Filings
  • 12/11/2020

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 11/25/2020

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 11/17/2020

Augmedix, Inc. (AUGX) - 8-K/A - Current report

  • SEC Filings
  • 11/16/2020

Augmedix, Inc. (AUGX) - D

  • SEC Filings
  • 10/19/2020

Augmedix, Inc. (AUGX) - SC 13D

  • SEC Filings
  • 10/15/2020

Augmedix, Inc. (AUGX) - 8-K - Current report

  • SEC Filings
  • 10/09/2020

Augmedix, Inc. (AUGX) - 4

  • SEC Filings
  • 10/07/2020

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 10/07/2020

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 10/01/2020

Augmedix, Inc. (AUGX) - SC 14F1

  • SEC Filings
  • 09/21/2020

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 08/13/2020

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 05/15/2020

Augmedix, Inc. (AUGX) - 10-K - Current report

  • SEC Filings
  • 03/30/2020

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 11/13/2019

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 08/13/2019

Augmedix, Inc. (AUGX) - 10-Q - Quarterly Report

  • SEC Filings
  • 05/20/2019

Augmedix, Inc. (AUGX) - 3

  • SEC Filings
  • 05/13/2019

Augmedix, Inc. (AUGX) - 10-12G

  • SEC Filings
  • 03/14/2019
Press Releases
StockPrice Release

Augmedix launches industry's first fully-automated, genai-powered, medical documentation product for emergency departments

  • 04/24/2024

Augmedix integrates with andor health to revolutionize ambient clinical documentation for ambulatory virtual care

  • 04/09/2024

Augmedix and sada forge partnership to scale ambient documentation and structured data products to health systems nationwide

  • 04/04/2024

Augmedix delivers 45% revenue growth and expanded gross margins for fourth quarter of 2023

  • 03/18/2024

Augmedix announces new positive data and enhancements to its ambient ai product, augmedix go

  • 03/12/2024

Augmedix to announce fourth quarter and full year 2023 financial results on march 18, 2024

  • 03/08/2024

Augmedix to participate in citizens jmp technology conference

  • 02/27/2024

Shareholder alert: purcell & lefkowitz llp announces shareholder investigation of augmedix, inc. (nasdaq: augx)

  • 02/22/2024

Augmedix names tomer levy as new senior vice president of engineering

  • 02/13/2024

Augmedix announces participation in maxim group virtual healthcare it investor conference

  • 01/16/2024

Augmedix exits calendar 2023 with expected $51 million in annual recurring revenue

  • 01/05/2024

Augmedix partners with google cloud to bring medically-tuned ai technology to ambient documentation

  • 12/13/2023

Augmedix partners with google cloud to bring medically-tuned ai technology to ambient documentation

  • 12/13/2023

Augmedix announces closing of public offering of common stock, including additional investments from hca healthcare and redmile group

  • 11/21/2023

Augmedix announces pricing of upsized public offering of 6,250,000 shares of common stock

  • 11/16/2023

Augmedix announces proposed public offering of 5,500,000 shares of common stock

  • 11/15/2023

Augmedix delivers 50% revenue growth and expanded gross margins for third quarter of 2023

  • 11/06/2023

Shareholder alert: purcell & lefkowitz llp announces shareholder investigation of augmedix, inc. (nasdaq: augx)

  • 11/02/2023

Augmedix to announce third quarter 2023 financial results and host investor conference call on november 6, 2023

  • 10/30/2023

Ellipsis health and augmedix to partner to bring automated mental health screenings to patient visits

  • 10/05/2023

Augmedix announces new ai medical documentation product, augmedix go, a clinician-controlled mobile app

  • 09/27/2023

Augmedix announces inaugural ai advisory council members

  • 09/21/2023

Augmedix achieves hitrust certification to further mitigate risk in third-party privacy, security and compliance

  • 08/24/2023

Augmedix announces participation in upcoming investor conferences in september 2023

  • 08/18/2023

Augmedix delivers 47% revenue growth and expanded gross margins for second quarter of 2023

  • 08/07/2023

Augmedix to announce second quarter 2023 financial results and host investor conference call on august 7, 2023

  • 07/28/2023

Shareholder alert: purcell & lefkowitz llp is investigating augmedix, inc. for potential breaches of fiduciary duty by its board of directors

  • 07/19/2023

Shareholder alert: purcell & lefkowitz llp is investigating augmedix, inc. for potential breaches of fiduciary duty by its board of directors

  • 06/15/2023

Augmedix extends term loan facility and finalizes terms for equity line of credit

  • 06/14/2023

Augmedix establishes ai advisory council to guide the company's continued development of high standard, responsible product development

  • 06/12/2023

Augmedix announces participation in upcoming investor conferences

  • 05/19/2023

Augmedix delivers continued sales momentum; reports first quarter 2023 financial results

  • 05/12/2023

Augmedix announces partnership with hca healthcare to accelerate the development of ai-enabled ambient documentation

  • 04/20/2023

Augmedix secures strategic financing from hca healthcare and redmile group

  • 04/20/2023

Augmedix reports strong commercial traction and sales momentum; reports fourth quarter and full year 2022 financial results

  • 03/27/2023

Augmedix to announce fourth quarter and full-year 2022 financial results and host conference call on march 27, 2023

  • 03/16/2023

Augmedix announces participation in oppenheimer's 33rd annual healthcare conference

  • 03/07/2023

Augmedix announces participation in maxim group healthcare it investor conference on january 25

  • 01/18/2023

Augmedix to attend the benchmark 2022 discovery one-on-one investor conference

  • 11/23/2022

Augmedix announces partnership with veterinary specialty center to support emergency veterinary and specialty care

  • 11/16/2022

Augmedix partners with kirby medical center to significantly reduce documentation burden for physicians and improve patient experiences

  • 10/04/2022

Augmedix to participate at the 2022 lytham partners fall investor conference

  • 09/15/2022

Augmedix launches new service, augmedix prep, to significantly reduce physician chart prep burden

  • 09/06/2022

Augmedix to present at the inaugural gilmartin group emerging growth company showcase

  • 08/17/2022

Augmedix - trio health - ciic first of its kind real-world patient ecosystem - standardizing relevant clinical data at the point of care

  • 08/03/2022

Augmedix to report second quarter 2022 financial results on august 8, 2022

  • 07/25/2022

Augmedix to present at the william blair 42nd annual growth stock conference

  • 05/26/2022

Augmedix to report first quarter 2022 financial results on may 9, 2022

  • 04/25/2022

Augmedix to participate at the 2022 lytham partners spring investor conference

  • 03/29/2022

Augmedix reports fourth quarter and full year 2021 financial results

  • 03/21/2022

Augmedix to report fourth quarter and full year 2021 financial results on march 21, 2022

  • 03/07/2022

Augmedix to participate at the 2022 jmp securities technology conference

  • 03/01/2022

Augmedix announces preliminary fourth quarter 2021 financial results

  • 01/31/2022

Augmedix to participate at the 11th annual lifesci partners corporate access event

  • 01/03/2022

American rheumatology network announces partnership with augmedix

  • 12/09/2021

Augmedix inc. (nasdaq: augx) leveraging asr, nlp tech to rehumanize healthcare

  • 12/08/2021

Augmedix, inc. to ring nasdaq closing bell today

  • 12/03/2021

Augmedix, inc. ceo appears on fox business network show

  • 12/03/2021

Augmedix, inc. announces uplisting to nasdaq and pricing of public offering of $40,000,000 of common stock

  • 10/25/2021

Augmedix announces preliminary third quarter 2021 financial results

  • 10/04/2021

Augmedix reports second quarter 2021 financial results

  • 08/10/2021

Augmedix announces partnership with medical advantage

  • 08/10/2021

Augmedix to present at the 2021 ld micro invitational xi

  • 05/27/2021
More Headlines
News

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

  • Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
  • 11/10/2023

Augmedix, Inc. (AUGX) Q3 2023 Earnings Call Transcript

  • Augmedix, Inc. (AUGX) Q3 2023 Earnings Call Transcript
  • 11/06/2023

Augmedix to Announce Third Quarter 2023 Financial Results and Host Investor Conference Call on November 6, 2023

  • SAN FRANCISCO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will report financial results for the third quarter ended September 30, 2023, on Monday, November 6, 2023, after the market closes. Management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • 10/30/2023

Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?

  • Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
  • 10/12/2023

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

  • If you are looking for stocks that are well positioned to maintain their recent uptrend, Augmedix, Inc. (AUGX) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
  • 10/09/2023

Augmedix: Using AI To Make Healthcare More Efficient

  • Augmedix offers AI-based solutions for the healthcare industry, allowing clinicians to spend more time on patient care. The company's solutions include remote medical documentation services and live clinical support services. Augmedix's above-average revenue growth makes it a promising stock with potential for long-term out-performance.
  • 10/03/2023

3 Best Breakout Stocks to Buy Now for Solid Returns

  • Lifeway Foods (LWAY), Augmedix (AUGX) and Clearwater Analytics Holdings (CWAN) have been selected as the breakout stocks for today.
  • 09/22/2023

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

  • Augmedix, Inc. (AUGX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
  • 09/21/2023

Are Medical Stocks Lagging Augmedix (AUGX) This Year?

  • Here is how Augmedix, Inc. (AUGX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
  • 09/12/2023

Recent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's Why

  • Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
  • 09/05/2023

Can Augmedix, Inc. (AUGX) Climb 36.06% to Reach the Level Wall Street Analysts Expect?

  • The average of price targets set by Wall Street analysts indicates a potential upside of 36.1% in Augmedix, Inc. (AUGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
  • 09/04/2023

Augmedix Announces Participation in Upcoming Investor Conferences in September 2023

  • SAN FRANCISCO, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that it will participate in the following investor conferences during September 2023.
  • 08/18/2023

Augmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's Why

  • Augmedix, Inc. (AUGX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
  • 08/16/2023

Why Shares of Augmedix Are Climbing on Tuesday

  • Augmedix offers software platforms for medical documentation designed to save physicians time. The company saw revenue climb by 47% year over year in the second quarter.
  • 08/08/2023

Augmedix, Inc. (AUGX) Q2 2023 Earnings Call Transcript

  • Augmedix, Inc. (NASDAQ:AUGX ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haasec - William Blair Neil Chatterji - B. Riley Securities Aaron Wukmir - Lake Street Capital Markets Allen Klee - Maxim Group LLC Operator Ladies and gentlemen, greetings, and welcome to the Augmedix Inc. Second Quarter 2023 Earnings Conference Call.
  • 08/07/2023

Augmedix, Inc. (AUGX) Reports Q2 Loss, Tops Revenue Estimates

  • Augmedix, Inc. (AUGX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.17 per share a year ago.
  • 08/07/2023

Augmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023

  • SAN FRANCISCO, July 28, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced it will report financial results for the second quarter ended June 30, 2023, on Monday, August 7, 2023, after the market closes. Company management will host a conference call that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • 07/28/2023

Augmedix Prepares For Continued Growth With HCA Collaboration

  • Augmedix provides ambient data collection software and services on doctor visits to increase medical care efficiencies. The firm recently announced an investment and collaboration partnership with major care provider HCA Healthcare. While the deal is still in its early stages, it could be a big boost to the company's future prospects and visibility.
  • 07/19/2023

3 Medical Info Systems Stocks to Consider From a Prospering Industry

  • Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.
  • 07/07/2023

Is Augmedix (AUGX) Stock Outpacing Its Medical Peers This Year?

  • Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
  • 06/16/2023

Is Augmedix (AUGX) Outperforming Other Medical Stocks This Year?

  • Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
  • 05/31/2023

Augmedix Announces Participation in Upcoming Investor Conferences

  • SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today announced that its leadership team will attend the following investor conferences during May and June 2023.
  • 05/19/2023

Augmedix, Inc. (AUGX) Q1 2023 Earnings Call Transcript

  • Augmedix, Inc. (NASDAQ:AUGX ) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company LLC Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Neil Chatterji - B. Riley Securities Operator Greetings, and welcome to the Augmedix Inc. First Quarter 2023 Earnings Conference Call.
  • 05/13/2023

Augmedix, Inc. (AUGX) Reports Q1 Loss, Tops Revenue Estimates

  • Augmedix, Inc. (AUGX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.16 per share a year ago.
  • 05/12/2023

Augmedix, Inc. (AUGX) Q4 2022 Earnings Call Transcript

  • Augmedix, Inc. (NASDAQ:AUGX ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Hasson - William Blair Neil Chatterji - B. Riley Securities Allen Klee - Maxim Group Operator Greetings, welcome to Augmedix Incorporated 2022 Fourth Quarter Earnings Conference Call.
  • 03/27/2023

Augmedix to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on March 27, 2023

  • Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023 Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023
  • 03/16/2023

Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25

  • SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast live at 12:30 p.m. ET. Mr. Krakaris and Paul Ginocchio, Chief Financial Officer, will also host investor meetings throughout the day.
  • 01/18/2023

Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference

  • SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Augmedix In c. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix's management will participate in one-on-one meetings with institutional analysts and investors throughout the day.
  • 11/23/2022

Augmedix, Inc. (AUGX) Q3 2022 Earnings Call Transcript

  • Augmedix, Inc. (NASDAQ:AUGX ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Ji-Yon Yi - Gilmartin Group LLC Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Charlie Montang - Lake Street Capital Markets, LLC Allen Klee - Maxim Group Operator Greetings and welcome to Augmedix, Inc. Third Quarter 2022 Earnings Call.
  • 11/14/2022

Augmedix to Participate at the 2022 Lytham Partners Fall Investor Conference

  • SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Fall Investor Conference.
  • 09/15/2022

Augmedix to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

  • SAN FRANCISCO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:50 a.m. ET.
  • 08/17/2022

Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q2 2022 Results - Earnings Call Transcript

  • Augmedix, Inc. (NASDAQ:AUGX ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Caroline Paul - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Allen Klee - Maxim Group Brooks O'Neil - Lake Street Capital Markets Operator Hello, and welcome to the Augmedix, Inc. Second Quarter 2022 Earnings Call.
  • 08/12/2022

Augmedix to Report Second Quarter 2022 Financial Results on August 8, 2022

  • SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • 07/25/2022

Augmedix to Present at the William Blair 42nd Annual Growth Stock Conference

  • SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago.
  • 05/26/2022

Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q1 2022 Results - Earnings Call Transcript

  • Augmedix, Inc. (NASDAQ:AUGX ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Caroline Paul - Investor Relations Manny Krakaris - Chief Executive Officer and Board Member Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B Riley FBR Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Operator Hello and welcome to the Augmedix, Inc. 2022 First Quarter Earnings Conference Call. All participants will be in listen-only mode.
  • 05/09/2022

Augmedix to Report First Quarter 2022 Financial Results on May 9, 2022

  • SAN FRANCISCO, April 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the first quarter of 2022 on Monday, May 9, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • 04/25/2022

Augmedix to Participate at the 2022 Lytham Partners Spring Investor Conference

  • SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Investors Conference, which will take place virtually from April 4 to April 7, 2022.
  • 03/29/2022

Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q4 2021 Results - Earnings Call Transcript

  • Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q4 2021 Results - Earnings Call Transcript
  • 03/21/2022

Augmedix to Report Fourth Quarter and Full Year 2021 Financial Results on March 21, 2022

  • SAN FRANCISCO, March 07, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the fourth quarter and full year 2021 on Monday, March 21, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • 03/07/2022

Augmedix: A Splendid Long-Term Investing Opportunity

  • Augmedix drives its revenue growth by reducing burnout of physicians who are highly productive.
  • 01/21/2022

U.S. IPO Weekly Recap: Semiconductors And Energy Storage Lead A Spooky 14 IPO Week

  • The IPO market remained active this past week as 13 IPOs raised $6.3 billion. SPAC activity kept steady with 13 blank check IPOs raising $2.1 billion.
  • 10/30/2021

Augmedix Announces Preliminary Third Quarter 2021 Financial Results

  • SAN FRANCISCO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced preliminary unaudited financial and operational results for the three months ended September 30, 2021.
  • 10/04/2021

Augmedix Begins U.S. Uplisting IPO Effort

  • Augmedix has filed to raise $40 million in a U.S. uplisting IPO to Nasdaq, although the final amount may differ.
  • 09/23/2021

Augmedix Reports Second Quarter 2021 Financial Results

  • SAN FRANCISCO, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today reported financial results for the three months ended June 30, 2021.
  • 08/10/2021

Augmedix Announces Partnership with Medical Advantage

  • Collaboration will Bring Augmedix's Solution to Physicians Nationwide – Alleviating Burnout, Increasing Efficiency, and Improving Patient Experience Collaboration will Bring Augmedix's Solution to Physicians Nationwide – Alleviating Burnout, Increasing Efficiency, and Improving Patient Experience
  • 08/10/2021

Augmedix to Present at the 2021 LD Micro Invitational XI

  • SAN FRANCISCO, May 27, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTCQX: AUGX), a leading provider of virtual medical documentation and live clinical support, today announced the company will be participating in the upcoming LD Micro Invitational XI investor conference.
  • 05/27/2021
Unlock
AUGX Ratings Summary
AUGX Quant Ranking